| Name | Title | Contact Details |
|---|
For more than a quarter of a century, Specialty Lighting Group has provided quality lighting products and design services for a variety of national clients. We create lasting value by offering a big companys expertise and resources with a small companys attention to service and detail. Be it a retail location or restaurant, we generate computerized lighting layouts and assist your designer or architect to ensure the lighting is appropriate for the application, energy-efficient, and available to meet your schedule. We also provide energy audits to assess the efficiency of your current lighting setup and figure out what utility rebates your company may be entitled to. Additionally, we provide a plan to increase the efficiency of your lighting and attempt to garner the greatest amount of utility rebates possible to save not only energy, but your money as well. With our large list of lighting and lamp vendors, we guarantee that we can provide you the perfect fixture or lamp for your project and our large inventory ensures that your lighting will arrive on time, no matter how tight your schedule may be. To find out more about Specialty Lighting Group, visit our website at www.sslighting.com, or watch the following video: http://sslighting.com/Images/specialty_lighting_wb.swf
IVP, a public listed company, was founded in 1929. We started with vegetable oils and later diversified into an array of fields We were originally part of the TATA Group but later got acquired by the Allanas. Today we are an integral part of the Allana Group. We were the first company to manufacture Foundry Chemicals in India in technical collaboration with M/s Ashland Inc way back in 1965 Our manufacturing plants at Tarapur and Bangalore have a combined annual capacity of approximately 50,000 MT per annum catering to the foundry, composites, refractory & insulation industries in India and neighboring countries.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Kerrie Kelly is a multifaceted design studio bringing thoughtful design into everyday life. To work with Kerrie Kelly—whether through residential interiors, corporate partnerships or lifestyle entertainment—is to gain a trusted, industry-savvy partner who bridges the gap between design principles and a life well lived.